Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Pierconti

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Neurological Research|July 1, 2006
Telomerase inhibition impairs tumor growth in glioblastoma xenograftsMaria Laura Falchetti, Paolo Fiorenzo, Maria Patrizia Mongiardi, et al.
Cancer|September 1, 2010
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosisRoberto Pallini, Lucia Ricci-Vitiani, Nicola Montano, et al.
Tumori|June 14, 2005
Metastatic tumors of the umbilicus: report of two cases and review of the literatureClaudio Coco, Alberto Manno, Alessandro Verbo, et al.
Diseases (Basel, Switzerland)|September 27, 2024
The Simultaneous Use of Bladder Epicheck<sup>®</sup> and Urinary Cytology Can Improve the Sensitivity and Specificity of Diagnostic Follow-Up of Urothelial Lesions: Up-to-Date Data from a Multi-Institutional CohortLudovica Pepe, Vincenzo Fiorentino, Cristina Pizzimenti, et al.
Urologic Oncology|August 11, 2020
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?Francesco Pierconti, Maurizio Martini, Vincenzo Fiorentino, et al.
Biomedicines|December 23, 2023
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid ResultFrancesco Pierconti, E D Rossi, V Fiorentino, et al.
BMC Cancer|May 12, 2018
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastomaMaurizio Martini, Ivana de Pascalis, Quintino Giorgio D'Alessandris, et al.
Clinical Genitourinary Cancer|December 21, 2025
Urothelial Carcinoma In Situ: Advances in Diagnosis and ManagementGabriele Ricciardi, Pietro Tralongo, Francesco Pierconti, et al.
Journal of Clinical Pathology|June 13, 2020
Methylation study of the Paris system for reporting urinary (TPS) categoriesFrancesco Pierconti, Maurizio Martini, Tonia Cenci, et al.
Blood|July 2, 2002
The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemiaLuciana Teofili, Francesco Pierconti, Annalaura Di Febo, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Neurological Research|July 1, 2006
Telomerase inhibition impairs tumor growth in glioblastoma xenograftsMaria Laura Falchetti, Paolo Fiorenzo, Maria Patrizia Mongiardi, et al.
Cancer|September 1, 2010
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosisRoberto Pallini, Lucia Ricci-Vitiani, Nicola Montano, et al.
Tumori|June 14, 2005
Metastatic tumors of the umbilicus: report of two cases and review of the literatureClaudio Coco, Alberto Manno, Alessandro Verbo, et al.
Diseases (Basel, Switzerland)|September 27, 2024
The Simultaneous Use of Bladder Epicheck<sup>®</sup> and Urinary Cytology Can Improve the Sensitivity and Specificity of Diagnostic Follow-Up of Urothelial Lesions: Up-to-Date Data from a Multi-Institutional CohortLudovica Pepe, Vincenzo Fiorentino, Cristina Pizzimenti, et al.
Urologic Oncology|August 11, 2020
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?Francesco Pierconti, Maurizio Martini, Vincenzo Fiorentino, et al.
Biomedicines|December 23, 2023
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid ResultFrancesco Pierconti, E D Rossi, V Fiorentino, et al.
BMC Cancer|May 12, 2018
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastomaMaurizio Martini, Ivana de Pascalis, Quintino Giorgio D'Alessandris, et al.
Clinical Genitourinary Cancer|December 21, 2025
Urothelial Carcinoma In Situ: Advances in Diagnosis and ManagementGabriele Ricciardi, Pietro Tralongo, Francesco Pierconti, et al.
Journal of Clinical Pathology|June 13, 2020
Methylation study of the Paris system for reporting urinary (TPS) categoriesFrancesco Pierconti, Maurizio Martini, Tonia Cenci, et al.
Blood|July 2, 2002
The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemiaLuciana Teofili, Francesco Pierconti, Annalaura Di Febo, et al.
Pageof 12